LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 1 | M06 | 72 | hr | 1235 | 4408 | 4355 | 1.0120 | 1.0131 |
| MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 2 | M06 | 72 | hr | 1235 | 3456 | 4277 | 0.8080 | 0.7755 |
| MDA-MB-231 | HG-6-64-01 | 0.04 | uM | LJP6 | 3 | M06 | 72 | hr | 1235 | 4086 | 4583 | 0.8915 | 0.8821 |
| MDA-MB-231 | HG-6-64-01 | 0.12 | uM | LJP6 | 1 | M05 | 72 | hr | 1235 | 3613 | 4355 | 0.8294 | 0.8044 |
| MDA-MB-231 | HG-6-64-01 | 0.12 | uM | LJP6 | 2 | M05 | 72 | hr | 1235 | 3432 | 4277 | 0.8024 | 0.7686 |
| MDA-MB-231 | HG-6-64-01 | 0.12 | uM | LJP6 | 3 | M05 | 72 | hr | 1235 | 3217 | 4583 | 0.7019 | 0.6585 |
| MDA-MB-231 | HG-6-64-01 | 0.37 | uM | LJP6 | 1 | M04 | 72 | hr | 1235 | 2159 | 4355 | 0.4957 | 0.3593 |
| MDA-MB-231 | HG-6-64-01 | 0.37 | uM | LJP6 | 2 | M04 | 72 | hr | 1235 | 2014 | 4277 | 0.4709 | 0.3134 |
| MDA-MB-231 | HG-6-64-01 | 0.37 | uM | LJP6 | 3 | M04 | 72 | hr | 1235 | 1823 | 4583 | 0.3977 | 0.2282 |
| MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 1 | M03 | 72 | hr | 1235 | 1588 | 4355 | 0.3646 | 0.1479 |
| MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 2 | M03 | 72 | hr | 1235 | 910 | 4277 | 0.2128 | -0.1571 |
| MDA-MB-231 | HG-6-64-01 | 1.11 | uM | LJP6 | 3 | M03 | 72 | hr | 1235 | 1733 | 4583 | 0.3781 | 0.1957 |
| MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 1 | M02 | 72 | hr | 1235 | 1082 | 4355 | 0.2484 | -0.0706 |
| MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 2 | M02 | 72 | hr | 1235 | 502 | 4277 | 0.1174 | -0.3953 |
| MDA-MB-231 | HG-6-64-01 | 3.33 | uM | LJP6 | 3 | M02 | 72 | hr | 1235 | 1471 | 4583 | 0.3209 | 0.0965 |
| MDA-MB-231 | HG-6-64-01 | 10 | uM | LJP6 | 1 | M01 | 72 | hr | 1235 | 212 | 4355 | 0.0487 | -0.6210 |
| MDA-MB-231 | HG-6-64-01 | 10 | uM | LJP6 | 2 | M01 | 72 | hr | 1235 | 98 | 4277 | 0.0229 | -0.7571 |
| MDA-MB-231 | HG-6-64-01 | 10 | uM | LJP6 | 3 | M01 | 72 | hr | 1235 | 392 | 4583 | 0.0855 | -0.4552 |
| MDA-MB-231 | Neratinib | 0.04 | uM | LJP5 | 1 | A18 | 72 | hr | 1235 | 4638 | 4474 | 1.0365 | 1.0390 |
| MDA-MB-231 | Neratinib | 0.04 | uM | LJP5 | 2 | A18 | 72 | hr | 1235 | 4730 | 4578 | 1.0331 | 1.0347 |
| MDA-MB-231 | Neratinib | 0.04 | uM | LJP5 | 3 | A18 | 72 | hr | 1235 | 4733 | 4929 | 0.9602 | 0.9597 |
| MDA-MB-231 | Neratinib | 0.12 | uM | LJP5 | 1 | A17 | 72 | hr | 1235 | 4650 | 4474 | 1.0392 | 1.0418 |
| MDA-MB-231 | Neratinib | 0.12 | uM | LJP5 | 2 | A17 | 72 | hr | 1235 | 4451 | 4578 | 0.9721 | 0.9703 |
| MDA-MB-231 | Neratinib | 0.12 | uM | LJP5 | 3 | A17 | 72 | hr | 1235 | 4494 | 4929 | 0.9117 | 0.9095 |
| MDA-MB-231 | Neratinib | 0.37 | uM | LJP5 | 1 | A16 | 72 | hr | 1235 | 3546 | 4474 | 0.7925 | 0.7644 |